rosiglitazone has been researched along with Diathesis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Huang, C; Huang, Y; Li, R; Wang, W; Wang, X; Zhang, H | 1 |
| Benthem, L; Boersma, G; Scheurink, AJ; Steimer, TJ; van Dijk, G | 1 |
| Bains, RK; Fairhall, KM; Flavell, DM; Le Tissier, P; Robinson, IC; Strom, M; Wells, SE | 1 |
| Adachi, M; Gonzalez, FJ; Gumucio, DL; Kurotani, R; Madison, BB; Marin, HE; Morimura, K; Peters, JM; Sanford, M; Shah, Y; Young, HA | 1 |
4 other study(ies) available for rosiglitazone and Diathesis
| Article | Year |
|---|---|
Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling.
Topics: Animals; Aorta; Arteries; Disease Susceptibility; Endothelium, Vascular; Gene Expression Regulation; Hypertension; Insulin; Insulin Resistance; Male; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt; Rats; Rosiglitazone; Signal Transduction; Thiazolidinediones; Vasodilation | 2010 |
Pharmacological treatment of hyperinsulineamia in rats depends on coping style.
Topics: Adaptation, Psychological; Animals; Blood Glucose; Disease Susceptibility; Glucose Tolerance Test; Hyperinsulinism; Hypoglycemic Agents; Insulin; Male; Mifepristone; Rats; Rosiglitazone; Thiazolidinediones | 2011 |
Visceral obesity without insulin resistance in late-onset obesity rats.
Topics: Absorption; Animals; Animals, Genetically Modified; Body Temperature; Diet; Dietary Fats; Disease Susceptibility; Eating; Estradiol; Female; Glucose; Growth Hormone; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Obesity; Ovariectomy; Phenotype; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Time Factors; Viscera | 2004 |
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Topics: Animals; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Susceptibility; Epithelial Cells; Female; Inflammatory Bowel Diseases; Intestinal Mucosa; Ligands; Mice; Mice, Transgenic; Polymerase Chain Reaction; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2006 |